Offer - Urjas Oil for just ₹ 1 X
Combihale FF 250 Redicaps is a commercial drug that is prescribed in the form of Redicaps. The alternative uses of Combihale FF 250 Redicaps have also been explained below.
The optimal dosage of Combihale FF 250 Redicaps is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Combihale FF 250 Redicaps include Nosebleed, Chest tightness, Cough. Besides the aforementioned side effects, there are other adverse effects of Combihale FF 250 Redicaps as well, which are listed below. Such side effects of Combihale FF 250 Redicaps normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Combihale FF 250 Redicaps's effect is Moderate during pregnancy and Mild for lactating mothers. Further, the section on Combihale FF 250 Redicaps related warnings talks about Combihale FF 250 Redicaps's effects on the liver, heart and kidney.
Some other conditions that can be affected by Combihale FF 250 Redicaps are listed in the contraindications section below.
Additionally, Combihale FF 250 Redicaps may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Combihale FF 250 Redicaps, it is important to know that it is safe while driving, and is habit-forming.
Combihale FF 250 Redicaps is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Combihale FF 250 Redicaps safe for pregnant women?
Combihale FF may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Combihale FF again without your doctor's advice.
Is the use of Combihale FF 250 Redicaps safe during breastfeeding?
Side effects of Combihale FF on breastfeeding women are very mild.
What is the effect of Combihale FF 250 Redicaps on the Kidneys?
Using Combihale FF does not have any harmful effects on kidneys.
What is the effect of Combihale FF 250 Redicaps on the Liver?
There may be an adverse effect on the liver after taking Combihale FF. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Combihale FF 250 Redicaps on the Heart?
Combihale FF can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Combihale FF 250 Redicaps should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Combihale FF 250 Redicaps unless your doctor advises you to do so -
Is this Combihale FF 250 Redicaps habit forming or addictive?
No, there is no any evidence that Combihale FF 250 Redicaps is addictive.
Interaction between Food and Combihale FF 250 Redicaps
There isn't any research available on the side effects of taking Combihale FF 250 Redicaps with food.
Interaction between Alcohol and Combihale FF 250 Redicaps
Due to lack of research, there is no information about the side effects of taking Combihale FF 250 Redicaps with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359